Immunocore Ranked No 1 South East Company in the Annual Sunday Times Hiscox Tech Track 100
(Oxford, UK, 7 September 2015) Immunocore Limited, a world-leading biotechnology company developing novel T cell receptor (TCR) based biological drugs to treat cancer, viral infections and autoimmune disease, today notes that it has been ranked as the Number one company in the southeast region and number nine overall in the 15th annual Sunday Times Hiscox Tech Track 100.
The Sunday Times Hiscox Tech Track 100 league table ranks the top 100 private British technology, media and telecoms (TMT) companies with the fastest-growing revenues over the last three years. Immunocore appears in the league table for the first time as it has grown revenues exponentially to £6.4 million in 2014.
Tech Track 100 is compiled by Fast Track in association with The Sunday Times on an annual basis and adopts the London Stock Exchange’s techMARK definition of a technology company as one ‘that shows a commitment to innovation, research and product development, and operates in sectors including software, internet, telecoms and biotech’.
Eva-Lotta Allan, Chief Business Officer at Immunocore, commented: “We are delighted that our recent growth and performance has been recognised by inclusion in the prestigious Tech Track 100. TMT is one of the most exciting sectors in the UK and for Immunocore, which is a leading biotech company, to rank alongside some of the UK’s fastest growing and most innovative companies is a great source of pride for us.”
Please click on the link below to download the full Press Release: